PREVIEW

US Moves to Ease Marijuana Rules in Major Policy Shift. The U.S. Department of Justice has announced plans to loosen restrictions on certain marijuana products and fast-track efforts to reclassify the drug, marking one of the most significant shifts in U.S. drug policy in decades. While the move stops short of nationwide legalization, it could reshape the country’s $47 billion cannabis industry by reducing federal barriers that have long limited growth. Under the proposal, some medical marijuana products would be reclassified from highly restricted substances to a lower-risk category, placing them alongside drugs with accepted medical use and moderate abuse potential. Officials say the change could expand research, improve patient care, and make it easier for businesses to access funding. The policy push follows direction from Donald Trump, who has called for broader access to cannabis-derived products while maintaining safeguards against misuse. Supporters say the shift aligns federal policy more closely with science and state-level laws, while critics warn it could increase risks tied to higher potency products and broader access. With legal cannabis use already widespread across most U.S. states, the decision signals a major step toward redefining how the federal government approaches marijuana regulation.
Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT